Applications of the HE4 with other biochemical markers in carcinoma of endometrium and uterine cancer is assessed

Applications of the HE4 with other biochemical markers in carcinoma of endometrium and uterine cancer is assessed

  • CN 101,473,041 B
  • Filed: 01/04/2007
  • Issued: 11/14/2017
  • Est. Priority Date: 01/04/2006
  • Status: Active Grant
First Claim
Patent Images

1. specificity is used to assessing during whether patient suffer from the reagent of carcinoma of endometrium preparing for the antibody of HE4 or HE4a polypeptidesApplication, wherein in the humoral sample obtained from the patient HE4 or HE4a polypeptides expression rise show that patient suffers from uterusEndometrial carcinomas, wherein the humoral sample is blood, serum or plasma sample.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×